Stockysis — AI-Powered Stock News & Sentiment Analysis

HC Wainwright & Co. Reiterates Buy on Benitec Biopharma, Maintains $32 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 88.1%

Neg 0% Neu 88.1% Pos 0%

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:BNTC) with a Buy and maintains $32 price target.

Comments

No comments yet. Be the first!